merck glp 1 drug Medicare will negotiate Novo's GLP-1 price. Here's what that means for Ozempic, Wegovy Novo's Wegovy becomes first GLP-1
Description
IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits
Disclaimer: This article is for informational purposes only and is not medical advice
Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction
As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to incomeraising questions for both Medicaid and Medicare.
